Skip to main content

Lash & Brow Anatomy — The Biology Behind Healthier Lashes and Fuller Brows

Lash & Brow Anatomy

The Biology Behind Healthier Lashes and Fuller Brows
By Dr. Susan Lin, M.D. — Inventor on US Patent 8,206,695 | Reviewed May 2026

The short answer

Lashes and brows have fundamentally different anatomy from scalp hair: shorter growth cycles, different follicle density patterns, greater vulnerability to mechanical trauma, and proximity to the ocular surface (which makes safety paramount in any product designed to support them). This hub explains the biology of lash and brow growth, the most common causes of thinning, the ocular safety considerations behind a physician-formulated conditioner, and the science behind drug-free peptide conditioning.

I am the inventor on US Patent 8,206,695 (Eyelash Enhancement Composition and Method of Treatment) and lead author of the peer-reviewed clinical study on MD Lash Factor published in the Journal of Cosmetic and Laser Therapy in 2008. The clinical and patent work behind the MD lash and brow products informs everything in this guide.

How to use this knowledge center

Lash anatomy — the essentials

How many lashes do you have?

The average adult has approximately 90-160 lashes on the upper lid and 75-80 on the lower lid per eye. Distribution: 5-6 rows on the upper lid, 3-4 rows on the lower lid. Total: roughly 200-300 lashes per eye when healthy.

The lash growth cycle

Unlike scalp hair (which spends most of its time growing), lashes spend most of their cycle resting:

  • Anagen (growth): 30-45 days
  • Catagen (regression): ~15 days
  • Telogen (rest then shed): ~100 days
  • Total cycle: 4-11 months
  • Anagen ratio: only 35-40% of lashes in growth at any moment (vs 85-90% for scalp hair)
Eyelash Growth Cycle: Anagen 30-45 days, Catagen ~15 days, Telogen ~100 days Original clinical diagram of the eyelash growth cycle showing the three phases as a proportional timeline. Eyelash Growth Cycle Total cycle: 4–11 months · Only 35–40% of lashes in anagen at any moment ANAGEN Active growth phase 30–45 days CATAGEN Regression ~15 days TELOGEN Rest → shed ~100 days cycle restarts → 4–11 months total By contrast, scalp hair: 85–90% in anagen at any moment.
Figure 1. Eyelash growth cycle. Source: Lin, S. — Eyelashes: Anatomy and Conditioners for Increasing Length and Fullness/Thickness, Part 3.3.5 in Harry's Cosmeticology, 9th Edition, pp. 480–486.

This means visible lash improvement takes longer to manifest than scalp hair changes. Daily consistent use over 12-16 weeks is the realistic timeline for a complete cycle assessment.

Lash follicle structure

Lash follicles are specialized: they are angled to grow upward and outward, have larger sebaceous glands proportionally than scalp hair, and are located very close to the ocular surface. The proximity to the eye is what makes ocular safety the defining feature of any product designed to support lash health.

Brow anatomy — the essentials

How many brow hairs do you have?

The average adult has approximately 250-500 hairs per brow, with the density highest at the center (above the eye) and tapering toward the outer tail. Brow hairs grow at an angle that gives the brow its shape.

The brow growth cycle

Brow hairs cycle similarly to lashes: short anagen phase (4-5 months) and long telogen phase. Complete regrowth after damage or removal can take 4-6 months at minimum, with maximal density restoration over 9-12 months. Follicles that have been chronically over-tweezed for years may not fully regrow.

Why some brow thinning is permanent

Brow follicles can be permanently damaged by years of over-tweezing, certain medical treatments (chemotherapy, radiation), autoimmune conditions (frontal fibrosing alopecia, alopecia areata), or chronic mechanical trauma. Severely scarred follicles will not regrow even with optimal care.

Common causes of lash and brow thinning

Cause Lash impact Brow impact
Mechanical trauma (curlers, eye rubbing, harsh makeup removal) Major Minor
Over-tweezing or waxing N/A Major (can be permanent)
Hypothyroidism Moderate Major (outer third of brow classically thins)
Aging Gradual reduction Gradual reduction
Alopecia areata Can affect Can affect
Telogen effluvium (postpartum, stress, illness) Common Common

Ocular safety — why it matters for lash products

Because lash follicles sit just millimeters from the cornea, conjunctiva, and lacrimal duct, ocular safety is the defining feature of any responsibly formulated lash product.

MD Lash Factor is built around this principle. The patented formula (US Patent 8,206,695) is supported by an extensive independent safety dossier. In the peer-reviewed clinical study published in the Journal of Cosmetic and Laser Therapy in 2008 (PMID: 18569264, DOI: 10.1080/14764170802054138), MD Lash Factor was demonstrated to:

  • Lengthen and densify lashes in a statistically significant manner over 4 weeks
  • Show zero impact on visual acuity
  • Show zero impact on the lens, lacrimal ducts, or intraocular pressure
  • Be safe for contact lens wearers and sensitive eyes
MD Lash Factor Clinical Study — Lash Length Increase at 4 Weeks Bar chart showing 4-week lash length increase results from the 2008 Journal of Cosmetic and Laser Therapy randomized double-blind placebo-controlled trial. MD Lash Factor® Clinical Study — 4-Week Results Randomized, double-blind, placebo-controlled trial · n=34 · Choy & Lin, J Cosmet Laser Ther 2008 0.5 mm 1.0 mm 1.5 mm 2.0 mm Lash length increase (mm) 1.69 mm Group A Treatment 1.94 mm Group B Treatment 1.44 mm Group D Treatment 0.63 mm Group C Placebo All treatment groups p<0.05 vs placebo
Figure 2. MD Lash Factor® 4-week efficacy from the peer-reviewed randomized double-blind placebo-controlled clinical trial (n=34). Source: Choy, I., & Lin, S. F. (2008). J Cosmet Laser Ther, 10(2), 110–113. PMID 18569264.

This is the safety profile I formulated for. As a board-certified physician, I would not use — or recommend to my own patients — a lash product that compromised ocular safety for cosmetic gain.

Lash & Brow Frequently Asked Questions

Safety dossier, study results, daily-use guidance, and physician answers — all sourced from peer-reviewed and independent clinical research.

MD Lash Factor — Studies & Safety

Has MD Lash Factor been published in a peer-reviewed clinical trial?
Yes. A randomized, double-blind, placebo-controlled trial of MD Lash Factor was published in the Journal of Cosmetic and Laser Therapy in 2008. After 4 weeks of daily use, treated groups showed statistically significant lash lengthening compared with placebo. Source: Choy & Lin, J Cosmet Laser Ther, 2008.
What did the published MD Lash Factor study show?
Treated groups gained roughly 1.4 to 1.9 mm of lash length over 4 weeks, versus 0.6 mm for placebo — statistically significant. No serious adverse events were reported. Source: Choy & Lin, J Cosmet Laser Ther, 2008.
Has MD Lash Factor been independently tested for skin irritation?
Yes. An independent Repeated Insult Patch Test (RIPT) on over 200 participants found no clinically significant dermal irritation or sensitization. RIPT is the industry-standard screen used to confirm a topical product is non-irritating with repeated use. Source: Clinical Research Laboratories, Inc.
Has MD Lash Factor been tested for skin sensitization?
Yes. The Local Lymph Node Assay (LLNA) — the FDA-accepted standard for sensitization testing — confirmed MD Lash Factor is non-sensitizing. Source: Independent LLNA study.
Has MD Lash Factor been screened for genotoxicity?
Yes. The Ames bacterial mutagenicity assay across multiple Salmonella strains confirmed the active ingredient is non-mutagenic. Source: Independent Ames assay report.
Has MD Lash Factor been tested for ocular irritation in contact lens wearers and people with sensitive eyes?
Yes. A 4-week ophthalmologist-led in-use study on 35 women — including contact lens wearers and self-assessed sensitive-eye participants — found no impact on visual acuity, cornea, eyelid, conjunctiva, or contact lens integrity. Source: Clinical Research Laboratories, Inc.
Has MD Lash Factor been reviewed under EU cosmetic safety standards?
Yes. A formal Safety Assessment was completed by an independent qualified safety assessor in the United Kingdom, in accordance with EU Cosmetics Regulation EC 1223/2009. Source: Independent EU Safety Assessment Report, UK.
Is the science behind MD Lash Factor referenced in cosmetic-science textbooks?
Yes. Dr. Susan Lin authored the Eyelashes chapter (Part 3.3.5, pp. 480–486) of Harry's Cosmeticology, 9th Edition.
Why is MD Lash Factor considered one of the most rigorously studied lash conditioners on the market?
Few cosmetic lash conditioners carry the depth of independent safety and efficacy testing that MD Lash Factor does. The current public dossier includes: a peer-reviewed clinical trial (JCLT 2008), a 4-week ophthalmologist-led ocular irritation study at Clinical Research Laboratories in contact lens wearers and sensitive-eye participants, an independent RIPT on over 200 participants, a Local Lymph Node Assay, an Ames mutagenicity assay, a formal EU Safety Assessment under EC 1223/2009, and authorship of the lash growth chapter in Harry's Cosmeticology, 9th Edition.
Is MD Lash Factor recommended by physicians?
MD Lash Factor was formulated by Dr. Susan Lin, a board-certified physician in Obstetrics & Gynecology and Anti-Aging Medicine with 35+ years of practice (including MD Anderson, Memorial Sloan Kettering, NIH Scholar, Boston University School of Medicine, Kaiser Permanente, and California Medical Board affiliations). MD Lash Factor is patented (US Patent 8,206,695), ophthalmologist-tested, peer-reviewed, and used in physician practices.

MD Lash Factor — Daily Use & Special Situations

Can MD Lash Factor be used after eye surgery or while using prescription eye drops?
For users who have had eye surgery within the past 6 months or are currently using prescription eye drops, discontinue MD Lash Factor and consult the prescribing ophthalmologist before resuming.
Is MD Lash Factor safe to use during pregnancy or while breastfeeding?
There is no published clinical data on MD Lash Factor specifically in pregnant or nursing women, and as a general principle of medical caution most physicians recommend pausing optional cosmetic products during pregnancy and lactation.
What should I do if MD Lash Factor accidentally gets into the eye?
Rinse the eye gently with clean cool water for several minutes. If irritation persists beyond a few minutes after rinsing, contact your eye care professional.
Can MD Lash Factor be used with lash extensions or after a lash lift?
MD Lash Factor is applied as a thin line along the upper lash line (the skin at the lash base), not directly onto the lashes themselves, so it does not interfere with most lash extension adhesives or lash lift treatments.

MD Brow Conditioning Serum — Studies & Use

Has MD Brow Conditioning Serum been studied in a clinical trial?
Yes. An independent 56-day clinical study was conducted by Spincontrol, a French cosmetic-testing laboratory licensed by the French Health Products Safety Agency, on 23 subjects. Source: Spincontrol, 2010.
What did the 56-day MD Brow study show?
After 56 days of daily use, statistically significant majorities agreed that brows seemed thicker (78%), look better (83%), seem healthier (87%), seem more conditioned (78%), and seem more hydrated (87%). 96% found the product easy to apply. 87% agreed the product did not irritate eyes or skin. Source: Spincontrol, 2010 self-evaluation study (n=23, 56 days).
Was the brow study conducted by an independent lab?
Yes. Spincontrol is an independent contract research laboratory in France, licensed for cosmetic, dietary supplement, and medical device evaluation.
What makes MD Brow Conditioning Serum well-tolerated for daily use?
MD Brow is a dermatologist-tested cosmetic conditioner formulated by a physician with 35+ years of clinical practice. In the 56-day Spincontrol clinical study (n=23), 87% of participants agreed the product did not irritate the eyes or skin — a statistically significant result.
Can MD Brow help over-tweezed brows recover?
It can support the conditioning and visible regrowth phase, but biology limits what any topical product can do for follicles that have been chronically damaged.
Does MD Brow help with menopausal brow thinning?
Hormonal brow thinning (perimenopause and menopause) typically responds best to a combination of medical workup — to rule out hypothyroidism, ferritin deficiency, or autoimmune cause — plus topical conditioning. MD Brow supports the topical conditioning component.
Is MD Brow safe for sensitive skin?
Yes. In the 56-day Spincontrol independent clinical study, 87% of participants agreed MD Brow did not irritate the eyes or skin — a statistically significant result (p < 0.001).
How long until I see results with MD Brow?
Plan on a full 8–12 week assessment of daily use. The 8-week (56-day) Spincontrol study captured statistically significant agreement on thicker-looking, healthier, better-conditioned brows.

The MD scientific approach to lash and brow care

For lashes — MD Lash Factor

MD Lash Factor: physician-formulated daily conditioner. Patented (US 8,206,695), peer-reviewed for safety and efficacy, ophthalmologist-tested. Safe for contact lens wearers and sensitive eyes.

For brows — MD Brow Conditioning Serum

MD Brow: dermatologist-tested daily serum applied once nightly.

MD Brow Conditioning Serum 56-Day Independent Clinical Study Results Horizontal bar chart showing endpoint agreement percentages from the Spincontrol 56-day clinical study on MD Brow Conditioning Serum (n=23). MD Brow Conditioning Serum — 56-Day Study Independent self-evaluation study · Spincontrol · n=23 · % subjects agreeing 50% 75% 100% Easy to apply 96% No irritation 87% Healthier 87% More hydrated 87% Look better 83% Thicker 78% More conditioned 78% Look fuller 70% Darker 65% Statistically significant (p<0.05) Not statistically significant
Figure 3. MD Brow Conditioning Serum 56-day independent self-evaluation results. Source: Spincontrol — La Canada Ventures Inc. (2010), Study XX-MV01-WT-AT10, n=23. Endpoints in gold reached statistical significance by chi-square test at p<0.05.

In the 56-day clinical study, 78% of users agreed brows seemed thicker and more conditioned; 87% reported healthier, more hydrated-looking brows. 87% experienced no irritation.

About the author

Dr. Susan Lin, M.D. is a board-certified physician in Obstetrics & Gynecology and Anti-Aging Medicine. She is the inventor on US Patent 8,206,695 (Eyelash Enhancement Composition and Method of Treatment) and lead author of the peer-reviewed clinical study on MD Lash Factor published in the Journal of Cosmetic and Laser Therapy in 2008 (PMID: 18569264). She authored Part 3.3.5 — Eyelashes: Anatomy and Conditioners for Increasing Length and Fullness/Thickness (pp. 480–486) and Part 3.8 — Feminine Rejuvenation (pp. 549–560) in Harry's Cosmeticology, 9th Edition. Additional published works on hair and skin science include articles in The National Hair & Skin Journal (Fall 2012), The Link — American Hair Loss Council (2013), and Euro Cosmetics (April 2017).

Educational only; not a substitute for individualized medical advice.

Address:
448 N San Mateo Drive / San Mateo.CA 94401
La Canada Ventures, Inc. · NMSDC Certified MBE · WBENC Certified WBE · Veteran-Owned Small Business · U.S. Federal Contractor (SAM.gov GHQRVKN8GEG7) · GMP & FDA-Registered Manufacturing

.
MD®: Advanced Clinical Science. The official home of MD Lash Factor® and MD Hair™.

Home

Customer care

Support

Social

Address:
448 N San Mateo Drive / San Mateo.CA 94401
  • Amazon
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • iDEAL Wero
  • Mastercard
  • PayPal
  • Shop Pay
  • Venmo
  • Visa

© 2026 La Canada Ventures, Inc. All rights reserved. MD®, MD Lash Factor®, and MD Factor® are registered trademarks of La Canada Ventures, Inc. MD Hair™, MD Lash™, MD Skin™, and MD Wellness™ are trademarks of La Canada Ventures, Inc.

® denotes a trademark registered in the U.S.

Physician‑formulated by Dr. Susan Lin, M.D.
Powered by Omni Themes